: [12] EGR1 , [2] - [4] PMC 2025 : BPC-157 , , , , , , , [5]
But clinically, it presents with the same foundational issues: Insulin resistance Hormonal imbalance Poor metabolism Chronic inflammation All of these can trigger Hair Loss In Men, even as early as their late teens or early 20s
But it is important to remember the common adage, Absence of evidence does not mean evidence of absence. Just because the peptide doesnt have a lot of human studies doesnt make it worthless
PMID 21246600
Discontinuation due to side effects ran at 7% in Phase 2 data, which is lower than Semaglutides 11% discontinuation rate despite Semaglutide having a higher reported nausea incidence at 44%